Who has been buying Kolon Tissue Gin stock?

2 distinct insiders have filed 2 disclosed insider purchases in Kolon Tissue Gin (950160), most recently on 2026-05-12. Each filer, their role, the number of shares and the price at filing are listed in the table on this page.

How many insider filings does Kolon Tissue Gin have?

Kolon Tissue Gin has 2 buy-side and 0 sell-side disclosures on record, covering ₩27M ($19K) in total reported value, spanning 2024-05-31 to 2026-05-12.

Do insider buys in Korean stocks predict returns?

Not uniformly. StockDrifts analysed 170,720 share-count changes across 56,930 Korean regulatory filings using cross-sectional alpha at fixed forward horizons, and found returns concentrated in particular signal tiers rather than in insider buying generally.

Kolon Tissue Gin 950160

Company

코오롱티슈진Kolon Tissue Gin

Insiders

Buys

Total Value

₩27M ($19K)

Avg Return

+177.31%

Last Filing

2026-05-12

Kolon Tissue Gin (950160) has 2 disclosed insider purchases and 0 disclosed disposals on record, filed by 2 distinct insiders. Together those filings cover ₩27M ($19K) in reported transaction value. The earliest filing StockDrifts holds for Kolon Tissue Gin is dated 2024-05-31; the most recent is 2026-05-12. Across these filings the average return since disclosure is +177.31%, measured from each filing date to the latest available close.

Price & insider activity (12 months)

Recent insider trades

Date	Type	Source	Insider	Position	Shares	Price at filing	Return	Value
2026-08-06	BUY	Market Buy	노문종 Noh Moon-jong	CEO	582	₩17,570	+0.5%	₩10M ($7K)
2026-07-27	BUY	Market Buy	이규호 Gyuho Lee	Internal director	2.6K	₩15,910	-18.3%	₩42M ($29K)
2026-07-27	BUY	Market Buy	김정인 Kim Jeong-in	Managing Director	152	₩15,910	-18.3%	₩2M ($2K)
2026-07-27	BUY	Market Buy	전승호 Seungho Jeon	CEO	646	₩15,910	-18.3%	₩10M ($7K)
2026-05-12	SELL	교환	코오롱 cologne	-	-6.5K	₩138,800	+22.3%	₩901M ($626K)
2026-05-08	SELL	교환	코오롱 cologne	-	-3.0K	₩127,800	+15.6%	₩377M ($262K)
2026-03-25	BUY	제3자배정유상증자	코오롱 cologne	-	118.0K	₩102,300	+24.1%	₩12.1B ($8.4M)
2025-05-20	BUY	Market Buy	권순욱 Soonwook Kwon	Managing Director	200	₩36,800	+163.0%	₩7M ($5K)
2025-05-19	BUY	Market Buy	전승호 Seungho Jeon	CEO and President	603	₩33,200	+191.6%	₩20M ($14K)
2025-01-14	BUY	제3자배정유상증자	코오롱 cologne	-	373.4K	₩30,150	+221.1%	₩11.3B ($7.8M)
2024-07-05	BUY	행사가액조정	코오롱생명과학 Kolon Life Science	-	874	₩13,880	+597.4%	₩12M ($8K)
2024-05-31	BUY	제3자배정유상증자	코오롱 cologne	-	762.4K	₩14,260	+578.8%	₩10.9B ($7.5M)
2024-05-31	BUY	행사가액조정	코오롱생명과학 Kolon Life Science	-	2.6K	₩14,260	+578.8%	₩37M ($26K)

Frequently asked questions

Who has been buying Kolon Tissue Gin stock?: 2 distinct insiders have filed 2 disclosed insider purchases in Kolon Tissue Gin (950160), most recently on 2026-05-12. Each filer, their role, the number of shares and the price at filing are listed in the table on this page.
How many insider filings does Kolon Tissue Gin have?: Kolon Tissue Gin has 2 buy-side and 0 sell-side disclosures on record, covering ₩27M ($19K) in total reported value, spanning 2024-05-31 to 2026-05-12.
Do insider buys in Korean stocks predict returns?: Not uniformly. StockDrifts analysed 170,720 share-count changes across 56,930 Korean regulatory filings using cross-sectional alpha at fixed forward horizons, and found returns concentrated in particular signal tiers rather than in insider buying generally.

More on this data

Every trade listed above comes from an official regulatory disclosure. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.